Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 20, 2026

an hour ago

Global Vascular Access Device Market to Reach USD 8.68 Billion by 2031 | MarketsandMarkets™

GlobeNewswire

an hour ago

AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses

GlobeNewswire

2 hours ago

Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations

GlobeNewswire

2 hours ago

ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform

GlobeNewswire

2 hours ago

BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform

GlobeNewswire

2 hours ago

Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

GlobeNewswire

2 hours ago

HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.

GlobeNewswire

2 hours ago

AVIS À IGNORER -- BVI Medical, Inc.

GlobeNewswire

2 hours ago

$3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness

GlobeNewswire

2 hours ago

Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc.

GlobeNewswire

2 hours ago

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

GlobeNewswire

2 hours ago

First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

GlobeNewswire

2 hours ago

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

GlobeNewswire

3 hours ago

Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

GlobeNewswire

3 hours ago

Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa

GlobeNewswire

3 hours ago

Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare

GlobeNewswire

3 hours ago

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

GlobeNewswire

3 hours ago

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

GlobeNewswire

3 hours ago

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

GlobeNewswire

3 hours ago

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

GlobeNewswire